StonvexLoading…
StonvexStonvexStonvexCore line items from AX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $65.79M | $64.64M | $65.26M | $59.43M |
Operating Income | $613.39M | $635.48M | $431.74M | $339.96M |
Net Income | $432.91M | $450.01M | $307.17M | $240.72M |
EPS (Diluted) | $7.43 | $7.66 | $5.07 | $3.97 |
Total Assets | $24.78B | $22.86B | $20.35B | $17.40B |
Total Liabilities | $22.10B | $20.56B | $18.43B | $15.76B |
Cash & Equivalents | $1.93B | $1.98B | $2.23B | $1.57B |
Free Cash Flow OCF − CapEx | $436.12M | $269.52M | $166.49M | $195.12M |
Shares Outstanding | 56.48M | 56.89M | 58.94M | 59.78M |